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ABSTRACT
Human nasopharyngeal carcinoma (NPC) is a head and neck malignant tumor originating 
from the nasopharynx region. It is highly prevalent in Southern China and it is the fourth 
most common cancer in Malaysia. Recent studies have revealed that NPC are linked to 
ribosomal protein genes, particularly the large subunit ribosomal protein genes where it is 
found to have different expression patterns in NPC cell lines compared with normal human 
nasopharyngeal cell line. Hence, this research is conducted to study the gene expression of 
human ribosomal proteins genes, particularly RPeL13 and RPeL14 in normal human 
nasopharyngeal cell line, NP69 and nasopharyngeal carcinoma (NPC) cell lines, TW04, 
TWO1, HK1, HONE1 and SUNE-1 by using two step Reverse Transcriptase-Polymerase 
Chain Reaction (RT-PCR). This study revealed that RPeL14 transcript levels were detected 
in 2 out of 5 NPC cell lines, mainly TWO1 and HONE-1 while no RPeL13 transcript levels 
were identified in all six nasopharyngeal cell lines.
Key word: Ribosomal protein, nasopharyngeal carcinoma, RT-PCR, RPeL13, RPeL14
ABSTRAK
Karsinoma nasofarinks manusia (NPC) adalah tumor maglinan kepala dan leher yang 
berasal daripada kawasan nasofarinks. Penyakit kanser ini berleluasa di China Selatan dan 
merupakan kanser ke-empat yang paling kerap berlaku di Malaysia. Kajian kebelakangan 
ini telah menunjukkan bahawa NPC adalah berkait rapat dengan protein ribosom gen, 
terutamanya subunit besar protein ribosom gen yang didapati mempunyai corak gen 
ekspresi yang berlainan dalam garis sel NPC berbanding dengan garis sel normal epitelium 
nasofarinks. Jadi, kajian ini telah dijalankan untuk mengkaji ekspresi gen protein ribosom 
gen mamtsia, terutamanya RPeL13 dan RPeL14 dalam garis sel normal epitelium 
nasofarinks, NP 69 dan garis sel karsinoma nasofarinks TWO], TW04. HKI, HONE-1 dan 
SUNE-1 dengan rnenggunakan teknik dua langkah Reverse Transcriptase-Polymerase 
Chain Reaction (RT-PCR). Dalam kajian ini, tahap transkrip RPeL14 dalam dua garis sel 
telah dikerrrukakan antara lima garis sel NPC terutamanya TWO] dan HONE-1. Akan tetapi, 
RPeL13 transkrip tidak dapat dikesan dalam enam garis sel nasofarinks.
Kata kunci: Protein ribosoin, karsinoma nasofarinks, RT-PCR, RPeL13, RPeL14
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1.0 INTRODUCTION
Gene expression is a fundamental cellular process that involves a complex staging 
interaction of organelles, factors and molecules to produce a functional product in the cell. 
It consists of two main stages: transcription and translation. The ribosome, which is a crucial 
translational machinery for protein biosynthesis in gene expression, is made up of ribosomal 
protein (RP) genes and rRNAs. Ribosomal protein genes had always been found to play a 
crucial role in ribosome assembly and protein synthesis. Until recently, studies showed that 
RPs carry out extra-ribosomal functions such as apoptosis, DNA repair and cell migration. 
Many studies frequently associated mutations of RPs with developmental disorders and 
human diseases such as Diamond-Blackfan anemia (DBA), Shwachman-Diamond 
syndrome (SDS) and the progression of tumorigenesis that leads to cancer development.
Interestingly, there is an increasing number of research showing that ribosomal 
proteins are linked to NPC. Nasopharyngeal carcinoma (NPC) is a subset of head and neck 
squamous cell cancers with unique endemic distribution and etiological factors (Mutirangura 
et al., 1997). For many years, Epstein-Barr virus has been revealed to be an important factor 
for most nasopharyngeal carcinomas besides dietary and environmental reasons. Recent 
studies showed that there is strong evidence that genetic predisposition is involved in the 
genesis of NPC, among them are Human Leukocyte Antigen (HLA) gene, Glutathione S- 
transferase M1 (GSTMI), Polymeric immunoglobulin receptor (PIGR) and specific loci of 
chromosomal aberrations.
In ribosomal proteins, particularly from the large subunits in the ribosome have been 
shown to have different gene expression patterns in NPC cell lines, as compared to the 
normal nasopharyngeal cell line. For instance, Sim et al. (2016) found that
2
RPeL2 7, RPeL41, and RPeL43 genes are upregulated in NPC tumours. Another study by Hu
(2010) has also examined an upregulation of RPeL22 in her studies on NPC cell lines.
Despite numerous studies on NPC of the etiological causes of NPC, there has not 
been a significant evidence of these causes of the disease that correlates with NPC. One of 
the research problems of NPC is that 63.6% of the cases diagnosed are during its later stages 
(Azizah et al., 2015). This is because the signs and symptoms are often mistaken to be 
common illness such as nasal congestion, headache and sore throat. Hence, the development 
of suitable marker is important and essential in NPC for early detection (Cho, 2007).
In this research, RPeL13 and RPeL14 genes was studied to identify their transcript 
levels of expression in NPC cell lines. Previous studies showed that these ribosomal protein 
genes are found to be linked with other types of cancers, yet it is one of the pioneering studies 
to be done in NPC. Hence, the objective of this research is to compare the gene expression 
patterns of RPeL13 and RPeL14 between normal nasopharyngeal cell line, NP69 and NPC 
cell lines of TW01, TW04, HK1, HONE1 and SUNE1.
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2.0 Literature Review
2.1 Nasopharyngeal carcinoma (NPC)
Nasopharyngeal carcinoma (NPC) is one of the most common cancers originating in 
nasopharynx worldwide (Chen, 2015). It is a type of tumour arises from the surface epithelial 
lining situated at the upper part of the throat and behind the nostrils (Brennan, 2006), as 
shown in Figure 2.1.
Nasopharyngeal Tumor
ý`F ý
Figure 2.1: Origin of nasopharyngeal carcinoma (Yong, 2015).
NPC is a cancer that is particularly prevalent in South East Asia and Southern China (Yap, 
2015). In general, men are more susceptible to NPC than women. Based on the National 
Cancer Registry Report 2007-2011, the lifetime risk for males is 1 in 143 whereas for 
females is I in 417 in Malaysia. Moreover, Tiong & Selva (2015) reported that in Peninsular 
Malaysia is found to be most susceptible to NPC while in East of Malaysia, it is the Bidayu 
ethnic group (69.9-70.8%). In fact, Devi & Pisani (2004) studies concluded that the Bidayu 
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Figure 2.2: Age-standardised incidence rates of NPC across various populations in number of neNN cases per
000 population per year (Devi et. a/., 2004).
2.1.1 Etiological factors of NPC
100
Based on Gullo et al. (2008), earlier studies have suggested that dietary habits could be one of 
the major contributors to the oncogenic process. These include the ingestion of salted fish and 
preserved food that contain excessive amounts of carcinogenic compounds such as N- 
nitrosodimethyamine (NDMA), N-nitrospyrrolidene (NPYR) and N-nitrospiperidine (NPIP) 
(Gullo ei al., 2008). The exposure to smoke or chemical pollutants, including trace elements 
such as nickel have been reported to be associated with the development of NPC (Lu ei al., 
2010). Numerous studies have also showed that NPC is closely related to Eptein-Barr Virus 
(EBV) infection. Young & Dawson (2014) explained that the EBV infected patients with NPC 
may appear to be a consequence of virus latency in the premalignant epithelial cells that have 
already undergone genetic changes. Thus, the etiology of NPC is highly associated with a 
complex interaction of genetic, environmental and dietary factors (Cho, 2007).
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2.1.2 Histological classification
Since 1991, the World Health Organisation (WHO) had classified nasopharyngeal carcinoma 
into two subtypes: (Type 1) keratinised squamous cell carcinoma and (Type 2) non-keratinizing 
carcinoma. For Type 2, it is further subdivided into Type 2a, undifferentiated carcinoma and 
Type 2b, non-keratinizing undifferentiated carcinoma. However, studies showed that the 
distinction of NPC histological features can be unclear. In addition, the Chinese NPC 
classification has a more specific classification of NPC in comparison with the WHO 
classification. The consensus of NPC classification internationally still to be unified for better 
communication between researchers and medical officers (Wei et al., 2011). Hence in 2005, the 
use of numerical designation of WHO types 1, 2 and 3 was eliminated.
The current WHO classification retains the terminology of the 1991 classification, with 
the addition of one category: basaloid squamous cell carcinoma (Barnes et al., 2005). It is 
important to note that many studies published after that are still referring to the 1991 WHO NPC 
classification. According to Li & Zhong (2014), less than 0.2% of all NPCs are reported for 
basaloid squamous cell carcinoma in southern China. The NPC non-keratinizing carcinoma is 
the most common type, as stated by Brandon & Brenda (2013), in high-incidence areas they 
represent >95 % of all NPCs (compared with approximately 75 % of NPCs in low-incidence 
areas). It is also most common in endemic populations for Type 2, while the keratinizing and 
basaloid squamous cell carcinoma types tend to be more common in non-endemic populations 
(Bernard & Christopher, 2014). Nonkeratinizing NPCs also have a high association with 
positive EBV serologies, are more radiosensitive, and are more frequently associated with 
lymph node and distant metastasis (Brandon & Brenda, 2013).
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2.2 Nasopharvngcal carcinoma (NPC) cell lines
To date, there have been more than 20 NPC cell lines that has been established since 1975 
(Gullo, 2008). The NPC cell lines are usually characterized with their histological features and 
other properties such as EBV status, culturing method, patient's biodata etc. One of the first 
NPC cell line established was CNE-1, which is derived from a 58-year-old Chinese female with 
the histological type of well differentiated squamous cell carcinoma with a negative status of 
EBV (Zhang et al., 1982). It is important to note that most of the NPC cell lines are EBV 
negative, some was initially positive but lo such as CNE-2 and SUNE-1. C666 is the only cell 
line that does not lose the EBV genome upon cell culture passaging. Moreover, one of the most 
recent NPC cell line established is NPC43 that harbours the EBV genome (Lin et al., 2016). In 
this research, live NPC cell lines were being used namely TW 01, TW 04, HK 1, HONE 1 and 
SUNE 1.
2.2.1 TW 0 l
TWO!, that was used to be named as NPC-TW039 is a NPC cell line derived from a 64-year- 
old Taiwanese male patient that had not been treated. The cell line established has a nature of 
moderately differentiated keratinizing squamous cell carcinoma. Karyotypic analysis showed 
the presence ofmultiple chromosomal abnormality. With the use of Giemsa banding technique, 
it is illustrated with a chromosomal number of 98 on average. According to Lin et al., (1990), 
this cell line has the capability to produce a solid turn with 37 markers including translocation 
21, deletion 7 and isochromosome 5, just to name a few (Lin et al., 1990). This cell line has a 
capability of producing solid tumour mass when cells were transplanted to the nude mouse. 
However, TWO1 does not exhibit oncogenic expression and has a negative EBV status.
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2.2.1 TW 04
TW04 is a cell line derived 11Dm a 36-year-old Chinese male patient living in Taiwan. It has the 
histological feature of undifferentiated carcinoma and showed mild lymphocytic infiltration 
under microscopic examination. TW 04 had been passaged for more than 100 times and has a 
chromosomal number of 92 in average (Lin et al., 1990). No EBV antigen was found in this cell 
line. Some of the special characteristics reported in this cell line is its overexpression of onco- 
myc and strong expression of vimentin (Lin et cal., 1993).
2.2.1 HK I
HK I is established from a 59-year-old male Chinese patient with the histological feature of 
well differentiated squamous cell carcinoma. As mentioned by Huang and his team (1980). he 
was treated with radiation therapy in prior to the biopsy procedure and the tissue taken out was 
from a recurrent tumour. This cell line can be maintained in RPMI-1640 medium supplemented 
with 15 % fetal calf serum, to which 100 IU/ml penicillin and 100 & ml streptomycin PMI- 
1640. Based on the karyotype analysis, the cell line demonstrates an aneuploid with a modal 
chromosome number of 74 with both numerical and structural aberrations such as 
fragmentation, breakage, giant submetacentric chromosomes etc. HK1 cell line has a negative 
EBV status (Huang et al., 1980).
2.2.1 HONE-1
HONE-1 is a NPC cell line derived from a 68-year-old Chinese male patient, showing 
histological features of poorly differentiated squamous cell carcinomas under microscopic 
examination. HONE-1 was initially detected as EBV positive but EBV-encoded nuclear antigen 
(EBNA) expression was loss after a few passages during the initial establishment of the cell line
8
(Glaser et al., 1989). According to Strong and his team (2014) found that human papillomaviius 
18 (HPV-18) was detected through RNA sequencing and real-time reverse transcription-PCR 
(RT-PCR) analysis in HONE-1. Further analysis of the chromosomal integration arrangement 
of HPV-18 in NPCs revealed patterns identical to those observed in HeLa cells. This finding 
showed that the early cultures of HONE-1 may be contamination by HeLa cells.
2.2.1 SUNE-1
SUNE 1 is derived from a female patient of poorly differentiated squamous cell carcinomas. 
Clones of SUNE-1 were subcultured, namely 5-8F and 6-1 OB. Both subclones have high and 
low tumorigenic and metastatic properties respectively.
2.3 Ribosomal protein genes
The human genome consists of 80 ribosomal protein genes, each with a single-copy gene 
(Rodnina, & W intcrmeyer, 2011). These genes are active under every condition in every human 
cell type studied so far (Uechi et al., 2001). They are crucial house-keeping genes that code for 
the architecture proteins in ribosomes. These RP genes are crucial house-keeping genes that 
code for the architecture proteins in ribosomes, the machinery responsible for protein synthesis 
(Rodnina, & Wintermeyer, 2011).
2.3.1 Ribosomal biogenesis
Ribosomal proteins are deemed not only as components of ribosomes, as since the last two 
decades, evidences showed that the also play fundamental roles in ribosome biogenesis (Xu et 
al., 2016). Ribosomal biogenesis comprises the processing and folding of the pre-rRNA and its 
concomitant assembly with the ribosomal proteins (Kressler et al., 2010). For instance, some
9
RPs function as RNA chaperones, stabilize rRNAs and promote their correct folding for the 
assembly of ribosomal subunits into a ribosome, whereas other RPs, such as uS7, uS9, uS12, 
uS15, uLl, and uL18, are responsible for direct contact with tRNAs (de las Heras-Rubio et al., 
2014; Wilson & Doudna, 2012). These studies showed that ribosomal proteins are crucial for 
cellular growth and maintenance.
2.3.2 Functions beyond the ribosome 
Recent studies showed the roles of ribosomal proteins in the regulation of apoptosis, cell cycle 
arrest, cell proliferation, cell migration and invasion, and DNA damage repair (Xu et al., 2016; 
Wang, 2015). One of the significant examples was the RP-MDM2-p53 pathway. Several RPs 
such as RPuL5 and RPeL 15 were found to activate the p-53-dependent cell cycle arrest and 
apoptosis by directly interacting with MDM2 and inhibiting its E3 ubiquitin ligase activity 
towards p53 when in stress (Marval & Zhang, 2011; Wu et al., 1993). Studies by Zhang & Lu 
(2009) further related human cancer with the mutations and inactivation of RPs in the p-53 
pathway. One of the most recent studies showed that the deletion of ribosomal protein genes is 
a common vulnerability in human cancer especially involving with TP53 mutations. This 
situation may contribute to the risk of cancers (Ajore et al., 2017).
2.3.3 Ribosomal proteins and cancer development 
Ribosomal proteins such as RPuL5 and RPeL15 can activate pathways like the p53 system to 
induce apoptosis and cell arrest. However, studies had also shown that the perturbations of RPs 
were associated with the growth of tumours caused by nucleolar stress (Wang, 2015). Stress 
conditions in the nucleolus can be triggered by a variety of extracellular and intracellular insults 
that impair ribosomal biogenesis and function, such as chemicals, nutrient deprivation, DNA 
damaging agents, or genetic alterations (Zhang & Lu, 2009). It was conceivable that either
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impairment or hyperactivation of the process was associated with deregulation of cell growth, 
which would eventually cause tumorigenesis, thus, leading to the development of cancers in 
tissues (Xu, 2016). 
2.3.4 RP genes and NPC 
Several studies had showed that mainly the large subunits of ribosomal protein genes were 
linked with NPC. One of the recent findings of NPC cell lines in relation with ribosomal proteins 
was done by Sim et al. (2016) showing the overexpression of eL27, eL43 and eL41 in NPC cell 
lines. Another study done by Yang and his team (2005) explained that uL16 and eL21 might 
have the same function in proliferation due to its upregulation in NPC cell line that may facilitate 
its survival during the metastasis of it to other targeted organs. eL14 was also studied by 
Vasudevan (2015) in NPC cell line, HK I and the results showed that there was no gene 
expression in eL14. By far, there have been no associated and limited studies showing the 
correlation of eL13 and eL14 with NPC respectively. The genetic basis that underlies the 
metastasis of nasopharyngeal carcinoma remains poorly understood. Hence, more research 
needs to be done for the characterization of the ribosomal protein gene expression patterns in 
NPC.
II
2.4 Ribosomal protein gene of interest
2.4.1 Ribosomal protein 13 (RPeL13) gene
13 14 15 16 17 18
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Figure 2.3: Gene loci ol'ribosomal protein gene, RPeL14 among other RPs (Uechi ef al., 2001 ).
The RPeL 13 is a gene located at 16g24.3 that encodes for 60S ribosomal protein eL 13
as shown in Figure 2.3. Several studies had been shown that there was a correlation between
eL13 gene expression with cancer. Kobayashi and his team (2006) observed that eL13 was 
upregulated in gastrointestinal cancers. Two studies done by Kardos and his team (2013) & 
(2014) found out that eLl3 gene melanoma, cancers of the prostate, brain, lung, cervix, 
connective tissue, and hone. Although these studies suggested that eL13 plays an essential role 
in the progression of some malignancies. Uterine cancers with high relative RPeL13 tended to 
correlate with favorable survival, whereas prostate cancers with high RPeL 13 showed no 
differences in prognosis or clinical eatures (Dolezal el al.. 2017). While these studies showed 
the consistent upregulation trend of RPeL13 in cancers, these evidences show that the role of 
RPeL13 in different types of cancers are inconsistent in clinical correlations and needs further 
elucidation.
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2.4.2 Ribosomal protein 14 (RPeL14) gene
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Fi rvre 2.4: Gene loci of rihosomal protein gene. RPel. 14 among other RI (L cchi cr a!.. 2001 ). 
RPeL14 is a gene situated at chromosome 3, loci p21.3 that encodes for 60S ribosomal 
protein eL14 as shown in Figure 2.4. RPeL14 contains a polymorphic CTG repeat encoding a 
polyalanine tract. According to Shriver et. al. (1998), polyalanine regions are found in a number 
of genes of developmental significance, consistent with the regulatory roles reported for 
ribosomal proteins. Shriver and his team (1998) found out that at the loci where the eL14 gene 
is located at was consistently deleted in lung cancer, oral squamous cell carcinoma and renal 
cell carcinoma. Moreover, the loss of heterozygosity (LOH) regions of eL14 was also frequently 
observed in primary breast tumours and were detected in breast cancer metastases (Aaroe ei al., 
2010). Another study from Huang and her team (2006) showed that LOH of eL 14 was observed 
in 29 out of 68 (43%) tumours and decreased expression of the gene was detected in 31 out of 
49 (63%) carcinomas. Hence, these results indicated that the deletion of eL14 gene was 
correlated to a decrease of tumorigenesis. However, whether eL14 gene suppresses cancers 
remains unclear and needs further elucidation.
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2.5 Gene expression analysis - semi quantitative RT-PCR
The assessment of the gene expression profiles may explicate the molecular aspects of cancer 
progression. Thus, similarities and variations of gene expression profiles of cancer patients 
could be explored as potential biomarkers (Wei et at., 2016). Quantitative measurement of 
specific gene expression is a critically important tool in understanding basic cellular mechanism 
and effects of' various agents on cell function (Breijak et at., 2005). RT-PCR is a modified 
version of PCR by using reverse transcriptase to convert RNA into cDNA and amplified in PCR. 
It is commonly used for its high sensitivity in quantification of low abundance nucleotide 
samples. RT-PCR allows researchers to quantify specific RNA transcripts and to detect variation 
in expression levels under different experimental conditions (Marone et al., 2001).
2.4.2 Reference gene: GAPDH
A reference gene has an average expression that is independent of the biological process, 
treatment or disease that is studied (Vandesompele et a!., 2002). Vandesompele and his team 
(2002) stated that a housekeeping gene is assumed to be constant when experimental conditions 
affect tissue composition and gene expression levels simultaneously. And, Glyceraldehyde-3 
phosphate clehvdrogenase (GAPDH) gene is one of them. 12pl3.31 10 exons gene is expressed 
constitutively and encodes for an enzyme that is involved in energy yielding step of glycolysis, DNA 
repair, membrane fusion and transport (Tristan et a!., 2011). Due to its nature, it is a housekeeping 
gene, has also been widely used as a housekeeping gene to normalize the expression of genes in 
studies of NPC and other types of cancers (Ma et a!., 2016). According to Tong and his team 
(2009), Gf1PDH is one of the most optimal reference genes for gene expression studies in 
nasopharyngeal carcinoma (NPC).
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